Clear Street lowered the firm’s price target on AST SpaceMobile (ASTS) to $115 from $137 and keeps a Buy rating on the shares after Blue Origin’s New Glenn 3 mission experienced a second stage malfunction, resulting in AST’s BlueBird 7 satellite being deployed into a lower-than-planned orbit. While the roughly $23M satellite cost is expected to be covered by insurance, the firm now anticipate delays to AST’s 45 to 60 satellite target by year-end 2026, the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
High conviction ASTS bulls now have this Tradr ETFPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASTS:
- Why Is AST SpaceMobile Stock (ASTS) Tumbling Today? BlueBird 7 Failure Sends Shares Down 13%
- Why AST SpaceMobile Stock (ASTS) Is Down Today and Why Scotiabank Warns of More Pain Ahead
- AST SpaceMobile announces BlueBird 7 to de-orbit following launch
- New Partnership with T-Mobile (TMUS) Allows Canada’s Rogers to Finally Break into the U.S.
- Mixed options sentiment in AST SpaceMobile with shares down 4.01%